Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS
Open Access
- 27 July 2019
- journal article
- letter
- Published by Springer Nature in CVIR Endovascular
- Vol. 2 (1) , 1-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled TrialsJournal of the American Heart Association, 2018
- Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal ArteryCirculation, 2016
- Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal LesionsJACC, 2013
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011